US Navy quietly resumes railgun tests at White Sands, reviving interest in hypersonic electromagnetic weapons for future ...
Phased-array radars are great for all sorts of things, whether you’re doing advanced radio research or piloting a fifth-generation combat aircraft. They’re also typically very ...
The literature on physician-mediated interventions to reduce costs is scant and provides little guidance on effective strategies. Objectives: Provider organizations are increasingly entering ...
MedVersa, a generalist multimodal AI model trained on tens of millions of medical imaging instances to perform diverse radiology tasks within a single framework. The model matched or exceeded ...
SYDNEY/SINGAPORE, Feb 3 (Reuters) - Chinese semiconductor designer Montage Technology (688008.SS), opens new tab is set to price its Hong Kong listing at the top end of a range, raising as much as ...
For decades, businesses have been trapped in a cycle of painful, episodic change, launching massive re-engineering projects and investing in new IT systems, only to find their organization’s ...
The new CLA comes in both hybrid and electric flavors, and it is the latter we are focusing on here. Built around a newly designed battery pack, powered by more advanced motors, and running on a ...
The Defense Department is joining several other agencies in a top-to-bottom review of 8(a) small business contracts. In a video posted Friday to X, Defense Secretary Pete Hegseth said the department ...
The annual list spotlights the innovations poised to make the greatest impact on our world and shape the future of technology. This list reflects months of rigorous reporting, analysis, and research ...
PROVO, Utah, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Action Target Inc., the global leader in shooting range technology, will kick off celebrating its 40th anniversary at SHOT Show 2026, showcasing new ...
Chinese officials are reviewing Meta's $2 billion acquisition of artificial intelligence startup Manus for possible technology control violations, the Financial Times reported Tuesday, citing two ...
Sanofi said the U.S. Food and Drug Administration accepted a priority review to potentially expand the current age range for its Tzield type-1 diabetes drug to include children as young as one year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results